Are HIV positive patients resistant to statin therapy?

BACKGROUND: Patients with HIV are subject to development of HIV metabolic syndrome characterized by dyslipidemia, lipodystrophy and insulin resistance secondary to highly active antiretroviral therapy (HAART). Rosuvastatin is a highly potent HMG-CoA reductase inhibitor. Rosuvastatin is effective at...

Descripción completa

Detalles Bibliográficos
Autores principales: Johns, Kevin W, Bennett, Matthew T, Bondy, Gregory P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Short Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186312/
https://www.ncbi.nlm.nih.gov/pubmed/17958912
http://dx.doi.org/10.1186/1476-511X-6-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186312/
https://www.ncbi.nlm.nih.gov/pubmed/17958912
http://dx.doi.org/10.1186/1476-511X-6-27

Ejemplares similares